| Bavencio 20 mg/mL concentrate for solution for infusion EU/1/17/1214/001 |
Avelumab |
Merck Europe B.V. |
— |
| Bridion 100 mg/ml solution for injection EU/1/08/466/1-2 |
Sugammadex |
Merck Sharp & Dohme BV |
— |
| Campral EC 333mg Gastro-resistant tablets PA2286/007/001 |
Acamprosate calcium |
Merck Serono (Ireland) Limited |
Marketed |
| Cancidas 50 mg powder for concentrate for solution for infusion EU/1/01/196/001 |
Caspofungin |
Merck Sharp & Dohme BV |
— |
| Cancidas 70 mg powder for concentrate for solution for infusion EU/1/01/196/003 |
Caspofungin |
Merck Sharp & Dohme BV |
— |
| CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent) EU/1/25/1913/001-006 |
Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7F conjugated to CRM197, Pneumococcal polysaccharide serotype 8 conjugated to CRM197, Pneumococcal polysaccharide serotype 9N conjugated to CRM197 |
Merck Sharp & Dohme BV, |
— |
| Cardicor 1.25 mg film-coated tablets PA2286/004/001 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 10 mg film-coated tablets PA2286/004/006 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 2.5 mg film-coated tablets PA2286/004/002 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 3.75 mg film-coated tablets PA2286/004/003 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 5 mg film-coated tablets PA2286/004/004 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cardicor 7.5 mg film-coated tablets PA2286/004/005 |
Bisoprolol hemifumarate |
Merck Serono (Ireland) Limited |
Marketed |
| Cetrotide 0.25 mg powder and solvent for solution for injection EU/1/99/100/001 |
Cetrorelix acetate |
Merck Europe B.V. |
— |
| Cetrotide 0.25 mg powder and solvent for solution for injection EU/1/99/100/002 |
Cetrorelix acetate |
Merck Europe B.V. |
— |
| Crinone 8% w/w progesterone vaginal gel PA2286/001/001 |
Progesterone |
Merck Serono (Ireland) Limited |
Marketed |
| Cubicin 350 mg powder for solution for injection or infusion EU/1/05/328/001 |
Daptomycin |
Merck Sharp & Dohme BV |
— |
| Cubicin 500 mg powder for solution for injection or infusion EU/1/05/328/002 |
Daptomycin |
Merck Sharp & Dohme BV |
— |
| Cyanokit 5 g Powder for solution for infusion EU/1/07/420/002 |
Hydroxocobalamin |
Merck Sante s.a.s. |
— |
| Delstrigo 100 mg/300 mg/245 mg film-coated tablets EU/1/18/1333/001-002 |
Doravirine, Lamivudine, Tenofovir disoproxil fumarate |
Merck Sharp & Dohme BV, |
— |
| Efficib 50 mg/1000 mg film-coated tablets EU/1/08/457/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Efficib 50 mg/850 mg film-coated tablets EU/1/08/457/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV, |
— |
| EMEND 125 mg hard capsules EU/1/03/262/004-005 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| EMEND 125 mg hard capsules EMEND 80 mg hard capsules EU/1/03/262/006 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| Emend 125 mg powder for oral suspension EU/1/03/262/011 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| EMEND 80 mg hard capsules EU/1/03/262/001-003 |
Aprepitant |
Merck Sharp & Dohme BV, |
— |
| Erbitux EU/1/04/281/001 |
Cetuximab |
Merck Europe B.V. |
— |
| Erbitux EU/1/04/281/2-5 |
Cetuximab, chimeric antibody |
Merck Europe B.V. |
— |
| Ervebo solution for injection EU/1/19/1392/001 |
Recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine (Live Attenuated) |
Merck Sharp & Dohme BV, |
— |
| Esmeron 10 mg/ml solution for injection/infusion PA1286/058/001 |
Rocuronium bromide |
Merck Sharp & Dohme Ireland (Human Health) Limited |
Not marketed |
| Ezmekly 1 mg dispersible tablets EU/1/25/1950/001-002 |
Mirdametinib |
Merck Europe B.V. |
— |
| Ezmekly 1 mg hard capsules EU/1/25/1950/003 |
Mirdametinib |
Merck Europe B.V. |
— |
| Ezmekly 2 mg hard capsules EU/1/25/1950/004-005 |
Mirdametinib |
Merck Europe B.V. |
— |
| Gardasil EU/1/06/357/01-21 |
Quadrivalent human papillomavirus type 11 recombinant vaccine (in), Quadrivalent human papillomavirus type 16 recombinant vaccine (in), Quadrivalent human papillomavirus type 18 recombinant vaccine (in), Quadrivalent human papillomavirus type 6 recombinant vaccine |
Merck Sharp & Dohme BV, |
— |
| Gardasil 9 suspension for injection. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) EU/1/15/1007/001-004 |
Hpv type 6 l1 protein, Hpv type 11 l1 protein, Hpv 16 l1 protein, Hpv 18 l1 protein, Hpv type 31 l1 protein |
Merck Sharp & Dohme BV, |
— |
| Glucophage 1000 mg film-coated tablets PA2286/005/003 |
Metformin Hydrochloride |
Merck Serono (Ireland) Limited |
Marketed |
| Glucophage 500 mg film-coated tablets PA2286/005/001 |
Metformin Hydrochloride |
Merck Serono (Ireland) Limited |
Marketed |
| Glucophage 850 mg film-coated tablets PA2286/005/002 |
Metformin Hydrochloride |
Merck Serono (Ireland) Limited |
Marketed |
| Gonal-F EU/1/95/001/025 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/026 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/027 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F EU/1/95/001/031 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 1050 IU/1.75 mL powder and solvent for solution for injection EU/1/95/001/021 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 300 IU/0.48 mL solution for injection in pre-filled pen EU/1/95/001/033 |
Follitropin alfa |
Merck Europe B.V. |
— |
| Gonal-F 450 IU/0.72 mL solution for injection in pre-filled pen EU/1/95/001/034 |
Follitropin alfa |
Merck Europe B.V. |
— |
| GONAL-f 900 IU/1.44 mL solution for injection in pre-filled pen EU/1/95/001/035 |
Follitropin alfa |
Merck Europe B.V. |
— |
| HBVAXPRO EU/1/01/183/002 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/003 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/004 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/005 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |
| HBVAXPRO EU/1/01/183/006 |
Hepatitis b vaccine |
Merck Sharp & Dohme BV, |
— |